BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 31199581)

  • 1. MiR-34b-3p represses cell proliferation, cell cycle progression and cell apoptosis in non-small-cell lung cancer (NSCLC) by targeting CDK4.
    Feng H; Ge F; Du L; Zhang Z; Liu D
    J Cell Mol Med; 2019 Aug; 23(8):5282-5291. PubMed ID: 31199581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower miR-340 expression predicts poor prognosis of non-small cell lung cancer and promotes cell proliferation by targeting CDK4.
    Qin Y; Zhou X; Huang C; Li L; Liu H; Liang N; Chen Y; Ma D; Han Z; Xu X; He J; Li S
    Gene; 2018 Oct; 675():278-284. PubMed ID: 29935356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-323-3p Targeting Transmembrane Protein with EGF-Like and 2 Follistatin Domain (TMEFF2) Inhibits Human Lung Cancer A549 Cell Apoptosis by Regulation of AKT and ERK Signaling Pathways.
    Fan JM; Zheng ZR; Zeng YM; Chen XY
    Med Sci Monit; 2020 Feb; 26():e919454. PubMed ID: 32009129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-503-3p induces apoptosis of lung cancer cells by regulating p21 and CDK4 expression.
    Sun Y; Li L; Xing S; Pan Y; Shi Y; Zhang L; Shen Q
    Cancer Biomark; 2017 Dec; 20(4):597-608. PubMed ID: 28800319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-140-3p inhibits progression of non-small cell lung cancer by targeting Janus kinase 1.
    Hu C; Zou Y; Jing LL
    J Biosci; 2020; 45():. PubMed ID: 32345774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of NOB1 by microRNA-330-5p overexpression represses cell growth of non-small cell lung cancer.
    Kong R; Liu W; Guo Y; Feng J; Cheng C; Zhang X; Ma Y; Li S; Jiang J; Zhang J; Qiao Z; Qin J; Lu T; He X
    Oncol Rep; 2017 Oct; 38(4):2572-2580. PubMed ID: 28849232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of lncRNA MIR503HG suppresses proliferation and promotes apoptosis of non-small cell lung cancer cells by regulating miR-489-3p and miR-625-5p.
    Dao R; Wudu M; Hui L; Jiang J; Xu Y; Ren H; Qiu X
    Pathol Res Pract; 2020 Mar; 216(3):152823. PubMed ID: 31983569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-34b inhibits the migration/invasion and promotes apoptosis of non-small-cell lung cancer cells by YAF2.
    Zhuang XF; Zhao LX; Guo SP; Wei S; Zhai JF; Zhou QH
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2038-2046. PubMed ID: 30915747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-541-3p reverses cancer progression by directly targeting TGIF2 in non-small cell lung cancer.
    Lu YJ; Liu RY; Hu K; Wang Y
    Tumour Biol; 2016 Sep; 37(9):12685-12695. PubMed ID: 27448300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct repression of the oncogene CDK4 by the tumor suppressor miR-486-5p in non-small cell lung cancer.
    Shao Y; Shen YQ; Li YL; Liang C; Zhang BJ; Lu SD; He YY; Wang P; Sun QL; Jin YX; Ma ZL
    Oncotarget; 2016 Jun; 7(23):34011-21. PubMed ID: 27049724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-768-3p is involved in the proliferation, invasion and migration of non-small cell lung carcinomas.
    Xie Z; Chen W; Chen Y; Wang X; Gao W; Liu Y
    Int J Oncol; 2017 Nov; 51(5):1574-1582. PubMed ID: 29048613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-613 induces cell cycle arrest by targeting CDK4 in non-small cell lung cancer.
    Li D; Li DQ; Liu D; Tang XJ
    Cell Oncol (Dordr); 2016 Apr; 39(2):139-47. PubMed ID: 26744345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of miR-4286 is an unfavorable prognostic marker in individuals with non-small cell lung cancer.
    An X; Ge J; Guo H; Mi H; Zhou J; Liu Y; Weiyue ; Wu Z
    J Cell Biochem; 2019 Oct; 120(10):17573-17583. PubMed ID: 31111550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-204 suppresses non-small-cell lung carcinoma (NSCLC) invasion and migration by targeting JAK2.
    Wang P; Lv HY; Zhou DM; Zhang EN
    Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-34c-3p functions as a tumour suppressor by inhibiting eIF4E expression in non-small cell lung cancer.
    Liu F; Wang X; Li J; Gu K; Lv L; Zhang S; Che D; Cao J; Jin S; Yu Y
    Cell Prolif; 2015 Oct; 48(5):582-92. PubMed ID: 26250586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piperlongumine inhibits the growth of non-small cell lung cancer cells via the miR-34b-3p/TGFBR1 pathway.
    Lu X; Xu C; Xu Z; Lu C; Yang R; Zhang F; Zhang G
    BMC Complement Med Ther; 2021 Jan; 21(1):15. PubMed ID: 33413277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-338-3p suppresses cell proliferation and induces apoptosis of non-small-cell lung cancer by targeting sphingosine kinase 2.
    Zhang G; Zheng H; Zhang G; Cheng R; Lu C; Guo Y; Zhao G
    Cancer Cell Int; 2017; 17():46. PubMed ID: 28428733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 20. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
    Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C
    J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.